<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02553967</url>
  </required_header>
  <id_info>
    <org_study_id>REMASCO-1503</org_study_id>
    <nct_id>NCT02553967</nct_id>
  </id_info>
  <brief_title>Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)</brief_title>
  <acronym>REMASCO</acronym>
  <official_title>Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Oscar Lambret</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Oscar Lambret</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breast reconstruction is an integral part of the management of patients with breast cancer&#xD;
      and treated by total mastectomy. The aim of breast reconstruction is to get a satisfying&#xD;
      aesthetic and functional result (sensitivity) and that would enable the patient to&#xD;
      appropriate the reconstructed breast. Patient satisfaction assessed subjectively by&#xD;
      questionnaires would be better in autologous reconstructions than in reconstructions by&#xD;
      prosthesis.&#xD;
&#xD;
      The aim of our trial is to use functional MRI (fMRI) as an objective evaluation tool to&#xD;
      describe the brain functional changes of sensory projections after immediate or secondary&#xD;
      breast reconstruction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients responding criteria for selection and not objecting to participate in this trial&#xD;
      will address a quality of life questionnaire at baseline. Then the study procedures differ&#xD;
      depending on which group the patient belongs to.&#xD;
&#xD;
      Immediate breast reconstruction group : Six months after surgery (or six months after the&#xD;
      implantation of the definitive prosthesis in case of use of a tissue expander), a&#xD;
      postoperative fMRI will be performed and patients will be asked to complete a quality of life&#xD;
      form and a satisfaction form.&#xD;
&#xD;
      Secondary breast reconstruction group :&#xD;
&#xD;
        -  In the two months preceding the surgery, a preoperative fMRI will be performed.&#xD;
&#xD;
        -  Six months after surgery (or six months after the implantation of the definitive&#xD;
           prosthesis in case of use of a tissue expander), a postoperative fMRI will be performed&#xD;
           and patients will be asked to complete a quality of life form and a satisfaction form.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2016</start_date>
  <completion_date type="Actual">April 15, 2021</completion_date>
  <primary_completion_date type="Actual">November 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the non-operated breast.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the breast reconstructed using an autologous flap and a prosthesis.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the mastectomy scar before reconstruction.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Topography variation in brain sensory projection area after total mastectomy and breast reconstruction.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction score and pre and postoperative quality-of-life score (Breast Q) according to a Likert scale.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Immediate breast reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total mastectomy + immediate reconstructive surgery&#xD;
6 months after surgery : Functional MRI and questionnaires</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary breast reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Within 2 months before surgery : Functional MRI&#xD;
Reconstructive surgery&#xD;
6 months after surgery : Functional MRI and questionnaires</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Functional MRI</intervention_name>
    <description>Functional MRI</description>
    <arm_group_label>Immediate breast reconstruction</arm_group_label>
    <arm_group_label>Secondary breast reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient with an indication of unilateral total mastectomy with immediate breast&#xD;
             reconstruction for initial breast cancer or recurrence, Or patient undergoing a&#xD;
             unilateral secondary breast reconstruction&#xD;
&#xD;
          2. WHO performance status less than or equal to 2&#xD;
&#xD;
          3. Age â‰¥ 18 years&#xD;
&#xD;
          4. For patients of childbearing age, use of an effective contraceptive method for the&#xD;
             duration of the study&#xD;
&#xD;
          5. Patient having been informed and having signed an informed consent form for the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient undergoing a breast reconstruction by exclusive lipomodelling&#xD;
&#xD;
          2. Contraindication to MRI : claustrophobia, intra-orbital metallic fragment, pregnancy,&#xD;
             cochlear implants, incompatible metallic foreign body such as certain pacemaker and&#xD;
             mechanical valves&#xD;
&#xD;
          3. Patient with an indication of preoperative radiotherapy or adjuvant chemotherapy&#xD;
             according to regional and/or national standards&#xD;
&#xD;
          4. History of brain surgery&#xD;
&#xD;
          5. History of contralateral breast surgery&#xD;
&#xD;
          6. History of prophylactic total mastectomy&#xD;
&#xD;
          7. Reconstruction techniques using a mixed procedure (autologous + prosthesis)&#xD;
&#xD;
          8. Patient on medication that may alter the BOLD signal in MRI&#xD;
&#xD;
          9. Pregnant or breastfeeding women&#xD;
&#xD;
         10. Patient under tutorship or guardianship&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia REGIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Oscar Lambret</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional Magnetic Resonance Imaging (fMRI)</keyword>
  <keyword>Breast reconstructive surgery</keyword>
  <keyword>Breast Q questionnaire</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

